Bibliografie
- de BAST, C. MORIAME, N. WANET, J., LEDOUX, M. ACHTEN, G. & KENIS Y.-Bleomycin in Mycosis Fungoides and Reticulum Cell Lymphoma. Arch. Derm., 104, 508, 1971.
- BEDROSSIAN, C.W.M., LUNA, M.A., MACKAY. B. & LICHTINGER, B.-Ultrastructure of pulmonary bleomycin toxicity. Cancer, 32, 44, 1973.
- BLUM, R.H., CARTER, S.K. & AGRE, K.-A clinical review of bleomycin. Cancer, 31, 903, 1973.
- BROQUET, M.A., JACOT-DESCOMBE, MON TANDON, A. & ALBERTO, P.-Traitement des carcinomes epidermoides oro-pharyngolarynges par combinaison de Methotrexate et de Bleomycine. Schweiz. med. Wschr. 104, 18, 1974.
- de BRUX, J., DEROUT, J., DURANT, G. & WICART, L.-Controle d’action de la bleomycine sur les tumeurs. Nouv. Presse Med. 1, 511, 1972.
- BULL, C.A., NEWTON, N., DE WILDE, F. & CHEW, K.-Bleomycin in squamous-cell carcinoma. Med. J. Austr. 2, 704, 1972.
- CARBONE, P.P., KAPLAN, H.S., MUSHOFF, K. SMITHERS, D. & TUBIANA, M.-Report of the Comittee on Hodgkin’s disease staging classi fication. Cancer Res. 31, 1860, 1971.
- CHABNER, B.A., MYERS, C.E., COLEMAN, N. & JOHNS, D.-The clinical pharmacology of antineoplastic agents. New Engl. J. Med. 292, 1163, 1975.
- CUNNINGHAM, T.J., et al.-A clinical trial ol intravenous and intracavitary bleomycin. Cancer, 29, 1413. 1972.
- E.O.R.T.C. study-Study of the Clinical Efficiency of Bleomycin in Human Cancer. Brit. Med. J., 2, 643, 1970.
- GOLDMAN, J.M., DAWSON, A.A.-Combination therapy for advanced resistant Hodgkin’s Disease. Lancet, 2, 1224, 1975.
- HALMAN, K.E. et al.-Early Clinical Experience with Bleomycin in the United Kingdom. Brit. Med. J., 4, 635, 1972.
- HOMASSON, J.P., BOISSINOT, E. ROULLIER, A. & MOLINE, J.-Constance de l’alteration du transfert alveolo-capillaire chez I’homme par un agent anti-tumoral (bleomycine). Nouv. Presse Med. 3,1103, 1974.
- KIMURA, I.-Pulmonary Disorders induced by Bleomycin and their Prevention. Proc. 3rd Lung Cancer Meeting Tokyo, 211, 1970.
- KIMURA, I., ONOSHI, T. & KUNIMASA, I.-Treatment of malignant Lymphomas with Bleomycin. Cancer 29, 58, 1972.
- LUNA, M.A., BREDROSSIAN, C.W.M., LICHTINGER, B. & SALEM, P.-Interstitial Pneumonitis associated with Bleomycin Therapy. Am. J.C1. Path., 58, 501, 1972.
- MEYER, N.C. & SNOW, G.B.-Ervaringen met bleomycine bij tumoren in het hoofd hals gebied. Ned. T. Geneesk. 120, 237, 1976.
- MORET, R., ORTONNE, J.P., PERROT, H. & THIVOLET, J.-Exploration a la bleomycine marquee en dermatologie. Nouv. Presse Med. 3, 193, 1974.
- MOSHER, M.B., DE CONTI, R.C. & BERTINO, J.-Bleomycin therapy in advanced Hodgkin’s disease and epidermoied cancers. Cancer 30, 56, 1972.
- M.C.R. working party.-Bleomycin in advanced squamous cell carcinoma. Brit. Med. J. 1, 186, 1976.
- NOUEL, J.P., RENAULT, H. ROBERT, J., JEANNE, C. & WICART, L.-La bleomycine marquee au CO 57. Nouv. Presse Med. 0, 25, 1971.
- OHNUMA, T. et al.-Microbiological assay of bleomycin: inactivation, tissue dsitribution and clearance. Cancer 30, 914, 1972.
- RENAULT, H. RAPIN, J. & WICART, L.-La chelation de divers cations radioactifs par certains polypeptides, utilisee comme methode demarquage. Application a la Bleomycine. C. R. Acad. Sc. Paris, 273, 2013, 1971.
- ROBERT, J. et al.-Le diagnostic topographique des naevocarcinomes et de lours metastases a l’aide de bleomycine marquee. Bull. sc. fr. dermatol. syphil. 79, 166, 1972.
- ROSENOW, E.C.-The spectrum of DrugInduced Pulmonary Disease. Ann. Int. Med., 25, 977, 1972.
- ROUJEAU, J., NARCY, P., MARSAN, C. tk TROTOUX, J.-Fibrose Pulmonaire et Bleomycine. Sem. Hop. Paris, 49, 1989, 1973.
- SAITO, R. KANAGAMI, H. & NAGASH1MA, T.-Pulmonary changes caused by Bleomycin and Pulmonary Function. Proc. 3rd. Lung. Cancer Meeting, Tokyo, 29, 1970.
- SHASTRI, S. et al.-Clinical Study with Bleomycin. Cancer, 28, 1142, 1971.
- STUART, C.S., COLTMAN, C.A.-Therapy of Mycosis Fungoides with Bleomycin. Canccr 32 767, 1973.
- UMEZWA, T.-New Antibiotics, Bleomycin A and B. J. Antibiot. Tokyo, 19, 200, 1966.
- YAGODA, A. et al.-Bleomycin, an antitumor Antibiotic. Ann. Int. Med. 77, 861, 1972.